Home/Filings/4/0001104659-20-043696
4//SEC Filing

Truong Vu 4

Accession 0001104659-20-043696

CIK 0001614067other

Filed

Apr 5, 8:00 PM ET

Accepted

Apr 6, 4:15 PM ET

Size

5.1 KB

Accession

0001104659-20-043696

Insider Transaction Report

Form 4
Period: 2020-04-03
Truong Vu
DirectorCEO, CSO, Director10% Owner
Transactions
  • Exercise/Conversion

    Stock Options

    2020-04-03+50,000546,050 total
    Exercise: $5.24Exp: 2030-04-03Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The Stock Options vest in equal installments over 12 months, beginning on April 3, 2020.

Documents

1 file

Issuer

Aridis Pharmaceuticals, Inc.

CIK 0001614067

Entity typeother

Related Parties

1
  • filerCIK 0001749993

Filing Metadata

Form type
4
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 4:15 PM ET
Size
5.1 KB